Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02403141
Other study ID # IREC020
Secondary ID
Status Active, not recruiting
Phase N/A
First received March 25, 2015
Last updated March 1, 2017
Start date March 2015
Est. completion date March 2017

Study information

Verified date March 2017
Source Imperial College London Diabetes Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight [1]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance [2]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity [3]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1400
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria:

Participants aged between 18-64 years old. Both Gender male and female.

Exclusion Criteria:

Paediatrics below the age of 18. Any participant who is unable to take part

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire


Locations

Country Name City State
United Arab Emirates Imperial College London Diabetes Centre Abu Dhabi

Sponsors (1)

Lead Sponsor Collaborator
Imperial College London Diabetes Centre

Country where clinical trial is conducted

United Arab Emirates, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary objective (Establishing the prevalence of OSA in the study population.) Establishing the prevalence of OSA in the study population. 3 months
See also
  Status Clinical Trial Phase
Completed NCT02939586 - The Effect of Haemodialysis in Sleep Apnoea N/A
Completed NCT03638895 - Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service N/A
Active, not recruiting NCT02615431 - The Influence of MitraClip on Apnoea Asleep N/A
Completed NCT04071860 - Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
Completed NCT01861275 - Ischaemic Stroke and Sleep Apnea in Northern Part of Finland N/A
Completed NCT00708786 - Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implantable Cardioverter-Defibrillator (ICD) Patients Phase 4